Anaphylaxis after Pfizer Vaccine
from Evidence Based Medicine presented by InpharmD™
Early data suggests the incidence of true anaphylaxis to the Pfizer-BioNTech COVID-19 vaccine is rare (11.1 cases per million vaccine doses). Anaphylaxis is more common in women and persons with a history of allergies, and symptoms typically appear within 30 minutes of injection.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of Evidence Based Medicine presented by InpharmD™?
This episode is 6 minutes long.
When was this Evidence Based Medicine presented by InpharmD™ episode published?
This episode was published on February 26, 2021.
Can I download this Evidence Based Medicine presented by InpharmD™ episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.